Mukka Proteins Approves Unaudited Results, Acquires Full Ownership in Subsidiaries
Mukka Proteins approved unaudited financial results for Q3 FY26. The company will acquire full ownership in EPPL for ₹32.30 lakh and HMPPL for ₹19.64 lakh, making them wholly-owned subsidiaries. These acquisitions are strategic moves to expand alternate protein and core businesses, with completion targeted by June 30, 2026.
The acquisitions, while strategic, are of subsidiaries and do not represent a major merger or acquisition of a large entity. The financial results are also unaudited.
The company approved financial results and made strategic acquisitions to expand its business, which are positive developments.
Mukka Proteins Limited announced the outcome of its Board Meeting held on February 12, 2026. The Board approved the unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025. They also approved an amendment to the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders.
Furthermore, the company approved the acquisition of additional equity shares in Ento Proteins Private Limited (EPPL) and Haris Marine Products Private Limited (HMPPL), making both entities wholly-owned subsidiaries. The acquisition of EPPL involved 1,000 equity shares of face value Rs. 100 each for a total consideration of ₹32,30,000, aiming to expand the alternate proteins business. The acquisition of HMPPL involved 2,000 equity shares of face value Rs. 100 each for a total consideration of ₹19,64,000, to expand the core business. Both acquisitions are part of the company's strategic investment plans and are expected to be completed by June 30, 2026.
The Board Meeting commenced at 4:00 p.m. and concluded at 4:45 p.m.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.